Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.45 - $0.86 $8,276 - $15,817
18,393 New
18,393 $9,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $24,972 - $46,225
53,133 New
53,133 $31,000
Q1 2022

May 16, 2022

SELL
$0.75 - $1.77 $9,061 - $21,385
-12,082 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.56 - $2.93 $18,847 - $35,400
12,082 New
12,082 $20,000
Q4 2018

Feb 14, 2019

SELL
$3.43 - $6.19 $48,496 - $87,520
-14,139 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$4.75 - $14.5 $67,160 - $205,015
14,139 New
14,139 $67,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.